{
    "title": "Magnesium in Obesity, Metabolic Syndrome, and Type 2 Diabetes",
    "slug": "magnesium-in-obesity-metabolic-syndrome-and-type-2-diabetes",
    "aliases": [
        "/Magnesium+in+Obesity+Metabolic+Syndrome+and+Type+2+Diabetes+-+Jan+2021",
        "/13626"
    ],
    "tiki_page_id": 13626,
    "date": "2022-06-02",
    "categories": [
        "Diabetes",
        "Obesity",
        "Magnesium",
        "Metabolic Syndrome"
    ],
    "tags": [
        "Diabetes",
        "Magnesium",
        "Metabolic Syndrome",
        "Obesity",
        "diabetes",
        "health risk",
        "magnesium",
        "metabolic",
        "metabolic conditions",
        "metabolic syndrome",
        "metabolic syndrome and magnesium",
        "obesity"
    ]
}


{{< toc >}} 

---

#### Magnesium in Obesity, Metabolic Syndrome, and Type 2 Diabetes

Nutrients 2021, 13, 320. https://doi.org/10.3390/nu13020320

Gabriele Piuri1,+, Monica Zocchi h+ ,	1 ,	2 ,

Gian Vincenzo Zuccotti 1,3 , Luciano Pinotti 2 , Jeanette A. Maier1 and Roberta Cazzola 1,*0

Department of Biomedical and Clinical Sciences "L. Sacco", Università di Milano, 20157 Milan, Italy; gabriele.piuri@unimi.it (G.P.); monica.zocchi@unimi.it (M.Z.); matteo.dellaporta@unimi.it (M.D.P.); valentina.ficara@unimi.t (V.F.); gianvincenzo.zuccotti@unimi.it (G.V.Z.); jeanette.maier@unimi.it (J.A.M.)

Department of Health, Animal Science and Food Safety, Università di Milano, 20133 Milan, Italy; michele.manoni@unimi.it (M.M.); luciano.pinotti@unimi.it (L.P.)

Department of Pediatrics, Ospedale dei Bambini, 2154 Milan, Italy * Correspondence: roberta.cazzola@unimi.it

> These authors contributed equally to this work.

#### Chart of interactions

<img src="https://d378j1rmrlek7x.cloudfront.net/attachments/jpeg/mg-interactions.jpg" alt="image" width="600">

##### Magneium and Insulin

<img src="https://d378j1rmrlek7x.cloudfront.net/attachments/jpeg/mg-insulin.jpg" alt="image" width="600">

##### Magnesium Clinical Trials

<img src="https://d378j1rmrlek7x.cloudfront.net/attachments/jpeg/mg-clinical-yrials.jpg" alt="image" width="800">

Magnesium (Mg2+) deficiency is probably the most underestimated electrolyte imbalance in Western countries. It is frequent in obese patients, subjects with type-2 diabetes and metabolic syndrome, both in adulthood and in childhood. This narrative review aims to offer insights into the pathophysiological mechanisms linking Mg2+ deficiency with obesity and the risk of developing metabolic syndrome and type 2 diabetes. Literature highlights critical issues about the treatment of Mg2+ deficiency, such as the lack of a clear definition of Mg2+ nutritional status, the use of different Mg2+ salts and dosage and the different duration of the Mg2+ supplementation. Despite the lack of agreement, an appropriate dietary pattern, including the right intake of Mg2+, improves metabolic syndrome by reducing blood pressure, hyperglycemia, and hypertriglyceridemia. This occurs through the modulation of gene expression and proteomic profile as well as through a positive influence on the composition of the intestinal microbiota and the metabolism of vitamins B1 and D.

 **<i class="fas fa-file-pdf" style="margin-right: 0.3em;"></i><a href="https://d378j1rmrlek7x.cloudfront.net/attachments/jpeg/ll-37-diabetes.jpg">Download the PDF from VitaminDWiki </a>**